PDS Biotechnology prices 7.33M shares at $1.50 in registered direct offering
PDS Biotechnology (PDSB) has entered into securities purchase agreements with new and existing healthcare focused institutional investors as ...
PDS Biotech Announces up to $22 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today ...